An estimated 70% of the population experiences a traumatic event at some point in their life, and up to 20% of these individuals go on to develop posttraumatic stress disorder (PTSD). PTSD is a debilitating condition that significantly reduces the quality of life and alters an individual’s ability to regulate fear and safety cues. Rodent […]
A45: Evaluation of the Safety of Various E. Coli Derived Tryptamine Compounds
Clinical trials on the use of psilocybin (PSL) to treat depression are promising, but still in preliminary stages. Additionally, they are confounded by the presence of hallucinations, which may not be necessary for its clinical effectiveness but create challenges when designing experiments. Results from our lab have also indicated potential antidepressant efficacy for a number […]